| Novo Nordisk Pharma AG - Refixia 3000 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | 66216 | | 04 | | Refixia 3000 IE | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B02BD04 | | Gerinnungsfaktor IX | | 19.12.2023 | | |
| | Composition | | Praeparatio cryodesiccata: nonacogum beta pegolum 3000 U.I., natrii chloridum, histidinum, saccharum 10 mg, mannitolum, polysorbatum 80, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, pro vitro corresp. natrium 0.972 mg/ml.
Solvens: histidinum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 1 ml corresp. natrium. | | Packungsbestandteile | | Solvens | | | Lyophilisat et solvant | | | | | | | | | BAG: Principe actif | Concentr. |
|---|
| Nonacogum beta Pegolum | 3000 UI |
| | | | Agents auxilliaires |
|---|
| Histidine |
| |
| Praeparatio cryodesiccata: | | | Lyophilisat et solvant | | | | | | | | Principe actif | Concentr. |
|---|
| Nonacogum beta Pegolum | 3000 UI |
| | BAG: Principe actif | Concentr. |
|---|
| Nonacogum beta Pegolum | 3000 UI |
| | | | Agents auxilliaires | Concentr. |
|---|
| Acidum Hydrochloridum ad Ph | | | Histidine | | | Mannitol | | | Sodium Chlorure | | | Natrii Hydroxidum ad Ph | | | Polysorbatum 80 | | | Saccharum | 10 mg |
| |
| Solvens | | | Lyophilisat et solvant | | | | | | | | | BAG: Principe actif | Concentr. |
|---|
| Nonacogum beta Pegolum | 3000 UI |
| | | | Agents auxilliaires |
|---|
| Acidum Hydrochloridum ad Ph | | Histidine | | Natrii Hydroxidum ad Ph |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 004 | | 5336.28 | 5516.05 | B | LS | Non |
|
|
